Halaman 3 - Limfoma folikular Dokter Terbaik - TOP-73 dokter

Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018 – Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang.

• 20 tahun pengalaman dalam hematologi anak
• Spesialisasi dalam mengobati kanker darah langka pada anak-anak
• Pasien dan keluarga menjulukinya sebagai 'sosok yang mentransplantasikan kehidupan'
• Bekerja di Hadassah Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Profesor Bosch adalah pemimpin ternama dunia dalam bidang Leukemia Limfositik Kronis (LLC) dan gangguan limfoproliferatif, dengan inovasi dalam analisis dan perawatan penyakit hematologi.

• Memimpin bidang uji klinis untuk LLC dan limfoma
• Menerbitkan lebih dari 100 artikel di jurnal ilmiah terkemuka
• Menjadi kepala Hematologi di IOB Institute of Oncology
• Melakukan penelitian klinis dan dasar mengenai LLC

Seorang profesor yang berspesialisasi dalam hematologi dan transplantasi sumsum tulang – Prof. Zuckerman menerapkan keahlian akademik yang mendalam untuk merawat pasien di Rambam Medical Center.

• Berfokus pada kanker hematologi dan onkologi transplantasi
• Memimpin unit spesialis hematologi dan transplantologi
• Profesor akademik – pemimpin dalam penelitian dan pendidikan medis
• Bagian dari pusat kanker multidisiplin terkemuka di Israel

Prof. Dr. Serdar Bedii Omay telah mempublikasikan 65+ artikel ilmiah di bidang hematologi dan transplantasi sumsum tulang, dengan pengalaman luas di bidang tersebut.

• Menjalani pelatihan di Fakultas Kedokteran Mie, Jepang dalam bidang hematologi molekuler
• Profesor Hematologi di Universitas Teknik Karadeniz
• Spesialisasi dalam penyakit dalam dan hematologi sejak 1990
• Menyusun 112 makalah pertemuan dan 34 presentasi konferensi

Associate Professor di bidang Hematologi dengan 50+ publikasi – Dr. Eren berspesialisasi dalam limfoma folikular di Rumah Sakit Universitas Biruni.

• Menyelesaikan pelatihan subspesialis Hematologi di Rumah Sakit Pelatihan dan Penelitian Istanbul
• Anggota European Society of Hematology dan Turkish Hematology Association
• Penerima Penghargaan Peneliti Muda di Kongres Hematologi Nasional
• Fasih berbahasa Inggris untuk konsultasi pasien internasional

Dr. Apak berspesialisasi dalam hematologi-onkologi anak dengan lebih dari 30 tahun pengalaman, termasuk terapi sel T CAR dan transplantasi sumsum tulang di Rumah Sakit Universitas Biruni.

• Kepala Divisi Hematologi-Onkologi Anak di Universitas Istanbul-Cerrahpaşa
• Menerbitkan 75 makalah internasional tentang onkologi anak
• Asisten editor untuk Turkish Pediatrics Archives Periodical
• Anggota dewan Masyarakat Pediatrik Turki

Prof. Baytan mengkhususkan diri dalam kanker anak seperti limfoma folikular, dengan pengalaman lebih dari 20 tahun di bidang hematologi pediatrik.

• Menempuh pendidikan di Universitas Uludağ, sebuah institusi terkemuka di Turki
• Menerbitkan 15 artikel di jurnal internasional terakreditasi
• Ahli dalam leukemia, limfoma, dan penyakit pendarahan pada anak
• Menulis 3 buku tentang hematologi pediatrik

Associate Professor Ali Hakan Kaya berspesialisasi dalam hematologi dan transplantasi sel punca, dengan pengalaman luas dalam menangani limfoma folikular.

• Menyelesaikan pelatihan subspesialis hematologi di Rumah Sakit Pendidikan dan Penelitian Onkologi Ankara
• Anggota dari berbagai perkumpulan bergengsi termasuk Hematologic Oncology Society
• Penerima beberapa penghargaan untuk penelitian di bidang onkologi hematologi
• Bekerja di Rumah Sakit Universitas Biruni, sebuah institusi medis terkemuka

Spesialisasi dalam pengobatan limfoma di Rumah Sakit Liv Vadistanbul – berfokus pada keganasan hematologi seperti limfoma folikular.

• Profesor dengan pengalaman luas di bidang hematologi
• Bekerja di unit transplantasi sel punca dan aferesis terapeutik
• Peran pendidikan dan administratif di rumah sakit terkemuka di Turki
• Pelatihan subspesialisasi di Rumah Sakit Onkologi Ankara